Future Microbiology

(The H4-Index of Future Microbiology is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 500 papers]. The publications cover those that have been published in the past four years, i.e., from 2019-10-01 to 2023-10-01.)
Pathogenesis, clinical manifestations and complications of coronavirus disease 2019 (COVID-19)77
RND efflux pumps in Gram-negative bacteria; regulation, structure and role in antibiotic resistance66
Long-term outcomes of pediatric infections: from traditional infectious diseases to long Covid47
Cell division protein FtsZ: from structure and mechanism to antibiotic target44
Regulating polymyxin resistance in Gram-negative bacteria: roles of two-component systems PhoPQ and PmrAB44
Type VI secretion system: a modular toolkit for bacterial dominance43
In vitrodetection of porphyrin-producing wound bacteria with real-time fluorescence imaging43
N-acetylcysteine as a potential treatment for COVID-1943
Clinical characteristics, activity levels and mental health problems in children with long coronavirus disease: a survey of 510 children40
Oteseconazole: an advance in treatment of recurrent vulvovaginal candidiasis35
Systemic mycoses: a potential alert for complications in COVID-19 patients31
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry: an emerging tool for studying the vectors of human infectious diseases29
Tackling antimicrobial resistance by exploring new mechanisms of antibiotic action28
Terpinen-4-ol attenuates quorum sensing regulated virulence factors and biofilm formation in Pseudomonas aeruginosa28
Nanoparticulate drug-delivery systems for fighting microbial biofilms: from bench to bedside28
Review of the use of nasal and oral antiseptics during a global pandemic27
Existing antiviral options against SARS-CoV-2 replication in COVID-19 patients27
Focus on the 2019 novel coronavirus (SARS-CoV-2)25
Antivirulence compounds: a future direction to overcome antibiotic resistance?25
COVID-19: it's all about sepsis25
Brincidofovir: understanding its unique profile and potential role against adenovirus and other viral infections24
Ceftobiprole versus daptomycin in Staphylococcus aureus bacteremia: a novel protocol for a double-blind, Phase III trial24
Quorum-sensing regulation of virulence factors in bacterial biofilm24
Rezafungin: a novel antifungal for the treatment of invasive candidiasis23